Daiwa Securities Group Inc. Boosts Stock Position in Cencora, Inc. $COR

Daiwa Securities Group Inc. increased its holdings in Cencora, Inc. (NYSE:COR) by 9.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 32,629 shares of the company’s stock after purchasing an additional 2,849 shares during the period. Daiwa Securities Group Inc.’s holdings in Cencora were worth $11,021,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. AustralianSuper Pty Ltd purchased a new position in Cencora in the 3rd quarter worth approximately $26,191,000. Chilton Investment Co. Inc. purchased a new position in Cencora in the 3rd quarter worth approximately $459,000. Advisors Asset Management Inc. lifted its holdings in Cencora by 40.3% in the 3rd quarter. Advisors Asset Management Inc. now owns 17,302 shares of the company’s stock worth $5,407,000 after purchasing an additional 4,973 shares in the last quarter. Lansforsakringar Fondforvaltning AB publ lifted its holdings in Cencora by 5.4% in the 3rd quarter. Lansforsakringar Fondforvaltning AB publ now owns 60,254 shares of the company’s stock worth $18,831,000 after purchasing an additional 3,073 shares in the last quarter. Finally, Rhumbline Advisers lifted its holdings in Cencora by 4.0% in the 3rd quarter. Rhumbline Advisers now owns 430,150 shares of the company’s stock worth $134,435,000 after purchasing an additional 16,539 shares in the last quarter. 97.52% of the stock is owned by hedge funds and other institutional investors.

Cencora Price Performance

COR opened at $274.94 on Friday. Cencora, Inc. has a 12-month low of $244.82 and a 12-month high of $377.54. The company has a current ratio of 0.95, a quick ratio of 0.59 and a debt-to-equity ratio of 3.40. The business’s fifty day simple moving average is $292.70 and its 200-day simple moving average is $330.55. The company has a market capitalization of $53.49 billion, a price-to-earnings ratio of 21.08, a PEG ratio of 1.48 and a beta of 0.59.

Cencora (NYSE:COR) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). Cencora had a return on equity of 135.20% and a net margin of 0.78%.The firm had revenue of $78.36 billion for the quarter, compared to the consensus estimate of $81.09 billion. During the same period in the previous year, the company posted $4.42 EPS. Cencora’s quarterly revenue was up 3.9% compared to the same quarter last year. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, equities research analysts anticipate that Cencora, Inc. will post 17.79 earnings per share for the current fiscal year.

Cencora declared that its board has initiated a share repurchase program on Thursday, May 21st that permits the company to buyback $2.00 billion in outstanding shares. This buyback authorization permits the company to reacquire up to 3.9% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s management believes its shares are undervalued.

Cencora Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were given a dividend of $0.60 per share. The ex-dividend date of this dividend was Friday, May 15th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.9%. Cencora’s dividend payout ratio is presently 18.40%.

Wall Street Analysts Forecast Growth

COR has been the topic of a number of research analyst reports. Evercore set a $360.00 price target on Cencora in a report on Wednesday, April 8th. Leerink Partners reaffirmed an “outperform” rating on shares of Cencora in a report on Tuesday, March 17th. Morgan Stanley set a $342.00 price objective on Cencora in a report on Friday, May 8th. Barclays boosted their target price on Cencora from $400.00 to $425.00 and gave the company an “overweight” rating in a research report on Friday, February 13th. Finally, Wells Fargo & Company cut their target price on Cencora from $429.00 to $331.00 and set an “overweight” rating on the stock in a research report on Monday, May 11th. Twelve analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $380.25.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.